By Colin Kellaher Akero Therapeutics shares lost two-thirds of their value and fell to a 52-week low on Tuesday after the biotechnology company said a Phase…
Markets – MarketWatch
Akero Shares Slide 68% on Study Miss; 89bio Shares Feel Fallout Markets – MarketWatch
